Solstice Advanced Materials, Inc. ((SOLS)) has held its Q1 earnings call. Read on for the main highlights of the call.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Solstice Advanced Materials, Inc. struck an upbeat tone on its latest earnings call, pointing to double‑digit revenue growth, strong cash generation and standout demand in key niches like electronic materials and nuclear. Management acknowledged margin pressure and some softer end markets but framed these as manageable headwinds against a backdrop of disciplined leverage and reaffirmed guidance.
Revenue Growth Exceeds Guidance
Solstice opened the year with net sales of $991 million in Q1 2026, up 10% from a year earlier and above the top end of its own guidance range. Management highlighted broad-based contributions across the portfolio, underscoring that the company is already tracking ahead of its initial expectations for the fiscal year.
Strong Segment Performance — Electronic Materials
Electronic Materials led the growth story, with net sales jumping 21% year over year to $109 million, supported by demand from semiconductor and display customers. The broader Electronic & Specialty Materials segment delivered 7% sales growth to $281 million, while adjusted EBITDA climbed 10% to $58 million and margins edged up to 20.8%.
Robust Refrigerants & Nuclear Demand
Refrigerants & Applied Solutions continued to power results, with segment net sales rising 12% to $711 million and refrigerants revenue alone up 19% to $389 million on strong regulatory‑driven demand. Nuclear revenue surged 27% to $107 million, and management repeatedly flagged this business as a strategic, high‑growth pillar for the company.
Cash Generation and Liquidity
The company translated growth into cash, producing $199 million of operating cash flow and $124 million of free cash flow in Q1. With $642 million in cash and equivalents plus a $1 billion undrawn revolver, Solstice reported about $1.6 billion of total liquidity, giving it ample flexibility to fund growth and navigate volatility.
Prudent Leverage
Solstice underscored its conservative balance sheet, finishing the quarter with $2.0 billion of long‑term debt and net debt around $1.3 billion. On a trailing 12‑month basis, that equates to a net leverage ratio near 1.4x adjusted EBITDA, leaving room for both organic investment and potential strategic moves.
Reaffirmed Full‑Year Guidance
Despite mixed margin dynamics, management reaffirmed its full‑year 2026 outlook for net sales of $3.9–$4.1 billion and adjusted EBITDA of $975 million–$1.025 billion. The company also maintained its adjusted EPS range of $2.45–$2.75 and its capital spending plan of $400–$425 million, signaling confidence in the durability of demand.
Targeted High‑Return Growth Investments
Growth spending is accelerating, with Q1 capital expenditures of $82 million, up 32% year over year and focused on high‑return projects. The centerpiece is a $200 million expansion to double Spokane sputtering target capacity, expected to deliver mid‑teens returns, alongside additional outlays in Spectra ballistic fibers and nuclear conversion capacity.
Shareholder Returns and Capital Allocation
Management reiterated its disciplined capital allocation framework, balancing reinvestment with direct shareholder returns. The board declared a quarterly dividend of $0.075 per share, unchanged from the prior quarter, while emphasizing that growth projects with attractive returns remain the primary use of excess cash.
Margin Pressure from Refrigerant Mix and R&D
Profitability lagged the strong top line, with adjusted EBITDA flat year over year at $249 million and margins slipping to 25.1%. The Refrigerants & Applied Solutions segment saw adjusted EBITDA fall 3% and margins compress more than five percentage points to 34.1%, mainly due to product mix shifts tied to the HFO transition and stepped‑up R&D spending.
GAAP Income Impacted by Stand‑Alone Costs
GAAP net income attributable to Solstice came in at $85 million, down from last year as the company absorbed higher SG&A and interest costs linked to its status as a stand‑alone public company. Management framed these items as structural but manageable, noting that underlying cash generation and adjusted profitability remain solid.
Segment Weakness — Building Solutions & Intermediate
Not all areas grew, as Building Solutions & Intermediate net sales dropped 8% to $167 million amid continued softness in construction activity. Management acknowledged the cyclical drag from weaker building markets but suggested that strength in other segments is offsetting this pressure for now.
One‑time / Elevated Noncontrolling Interest
Earnings were also affected by an unusually high noncontrolling interest charge of $20 million in the quarter, tied to strong ConverDyn margins and the consolidation of a joint venture. The company guided investors to assume a more typical noncontrolling interest run rate of roughly $10 million per quarter going forward.
Ongoing Transition Costs and Planned Downtime
Solstice continues to incur corporate transition and legacy services costs, planning about $30 million for the year after booking roughly $15 million in Q1. Guidance also bakes in a $10 million planned downtime expense in Q2, which will temporarily weigh on margins but is presented as non‑recurring in nature.
Geopolitical and Input‑Cost Risks
Management pointed to the conflict in the Middle East as a source of higher logistics and select raw material costs, including diesel, shipping and sulfuric acid. However, these inputs represent less than 10% of total material spend, and the company is pursuing price and cost recovery measures to limit profit erosion.
Flat or Soft Subsegments
Several smaller businesses were flat to only modestly higher, underscoring uneven end‑market conditions below the headline growth. Safety & Defense Solutions revenue held at $50 million, Research & Performance Chemicals was stable at $121 million, and Healthcare Packaging posted a modest 9% recovery following prior inventory destocking.
Forward‑Looking Guidance and Outlook
Looking ahead, Solstice expects Q2 net sales of $1.06–$1.10 billion and an adjusted EBITDA margin of roughly 25–26%, even after absorbing planned downtime costs. Management anticipates modest sequential margin expansion, driven by continued strength in Refrigerants, Nuclear, Electronic Materials and Safety & Defense Solutions, supported by a strong balance sheet and ongoing dividend.
Solstice Advanced Materials delivered a quarter that beat revenue guidance, generated strong cash and showcased high‑growth niches, even as margins absorbed mix and transition headwinds. With leverage low, guidance reaffirmed and investment focused on attractive projects, the company pitched a constructive near‑term setup that may appeal to investors seeking both growth and balance‑sheet discipline.

